Share
Manila: The Asian Development Bank (ADB) has joined with leading public health experts, vaccine regulators, and policy makers to form an advisory group to provide its developing member countries (DMCs) with expert technical and scientific advice on the quality, safety, and effectiveness of vaccines for the coronavirus disease (COVID-19) pandemic.
The Regional Vaccine Advisory Group held its first meeting today and will help ADB and its DMCs better understand the regulatory oversight, risk management strategies, and pharmacovigilance needed to safely introduce and monitor vaccine rollouts.
“For most of the world, including Asia and the Pacific, the pandemic continues to disrupt lives and economies, and, in some countries, it is intensifying,” said ADB President Masatsugu Asakawa. “ADB’s Regional Vaccine Advisory Group will help to safely introduce COVID-19 vaccines across Asia and the Pacific, and allow people to resume their lives, revive their economies, and in doi
ADB establishes advisory group for Covid-19 vaccines
philippinetimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from philippinetimes.com Daily Mail and Mail on Sunday newspapers.
ADB establishes advisory group for Covid-19 vaccines
southeastasiapost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from southeastasiapost.com Daily Mail and Mail on Sunday newspapers.
ADB Establishes High-Level Advisory Group for COVID-19 Vaccines
adb.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adb.org Daily Mail and Mail on Sunday newspapers.
India s Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralises both Alpha and Delta variants of coronavirus, the US National Institute of Health has said. The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the UK and India, respectively. The top American health research institute, which has a history of strong scientific collaboration with India, also said that an adjuvant developed with funding from it has contributed to the success of the highly efficacious Covaxin, which has been administered to roughly 25 million people till date in India and elsewhere.